Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Type 2 diabetes mellitus [ T2DM ] has quickly become the epidemic of the XXI century and
challenging global health . Estimates of the World Health Organization [ WHO ] indicate that
globally , from 1995 to date has nearly tripled the number of people living with diabetes
mellitus [DM ]. Resveratrol has been extensively studied as a regulator of glucose through
its antioxidant effects and protecting pancreatic β cells by activation of sirtuin -1 [ SIRT1
] dependent deacetylase nicotinamide adenine diphosphate [ NAD ]. Therefore, it is important
to know the effect of resveratrol on the glycemic variability [GV ] in patients with T2DM who
are not in control with metformin monotherapy based.